产品描述
*The optimal dilutions should be determined by the end user.
*Tips:
WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.
引用格式: Affinity Biosciences Cat# DF4247, RRID:AB_2836598.
展开/折叠
DKFZp686E07254; FLJ00340; FLJ34579; Lysp100b; Nuclear antigen Sp100; Nuclear autoantigen Sp 100; Nuclear autoantigen Sp-100; Nuclear autoantigen Sp100; Nuclear dot associated Sp100 protein; Nuclear dot-associated Sp100 protein; SP 100; SP100; SP100 HMG nuclear autoantigen; SP100 nuclear antigen; SP100_HUMAN; Speckled 100 kDa;
抗原和靶标
Widely expressed. Sp100-B is expressed only in spleen, tonsil, thymus, mature B-cell line and some T-cell line, but not in brain, liver, muscle or non-lymphoid cell lines.
- P23497 SP100_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MAGGGGDLSTRRLNECISPVANEMNHLPAHSHDLQRMFTEDQGVDDRLLYDIVFKHFKRNKVEISNAIKKTFPFLEGLRDRDLITNKMFEDSQDSCRNLVPVQRVVYNVLSELEKTFNLPVLEALFSDVNMQEYPDLIHIYKGFENVIHDKLPLQESEEEEREERSGLQLSLEQGTGENSFRSLTWPPSGSPSHAGTTPPENGLSEHPCETEQINAKRKDTTSDKDDSLGSQQTNEQCAQKAEPTESCEQIAVQVNNGDAGREMPCPLPCDEESPEAELHNHGIQINSCSVRLVDIKKEKPFSNSKVECQAQARTHHNQASDIIVISSEDSEGSTDVDEPLEVFISAPRSEPVINNDNPLESNDEKEGQEATCSRPQIVPEPMDFRKLSTFRESFKKRVIGQDHDFSESSEEEAPAEASSGALRSKHGEKAPMTSRSTSTWRIPSRKRRFSSSDFSDLSNGEELQETCSSSLRRGSGSQPQEPENKKCSCVMCFPKGVPRSQEARTESSQASDMMDTMDVENNSTLEKHSGKRRKKRRHRSKVNGLQRGRKKDRPRKHLTLNNKVQKKRWQQRGRKANTRPLKRRRKRGPRIPKDENINFKQSELPVTCGEVKGTLYKERFKQGTSKKCIQSEDKKWFTPREFEIEGDRGASKNWKLSIRCGGYTLKVLMENKFLPEPPSTRKKRILESHNNTLVDPCEEHKKKNPDASVKFSEFLKKCSETWKTIFAKEKGKFEDMAKADKAHYEREMKTYIPPKGEKKKKFKDPNAPKRPPLAFFLFCSEYRPKIKGEHPGLSIDDVVKKLAGMWNNTAAADKQFYEKKAAKLKEKYKKDIAAYRAKGKPNSAKKRVVKAEKSKKKKEEEEDEEDEQEEENEEDDDK
翻译修饰 - P23497 作为底物
Site | PTM Type | Enzyme | Source |
---|---|---|---|
A2 | Acetylation | Uniprot | |
S18 | Phosphorylation | Uniprot | |
T39 | Phosphorylation | Uniprot | |
Y50 | Phosphorylation | Uniprot | |
K55 | Ubiquitination | Uniprot | |
S65 | Phosphorylation | Uniprot | |
K70 | Ubiquitination | Uniprot | |
K87 | Ubiquitination | Uniprot | |
S92 | Phosphorylation | Uniprot | |
S111 | Phosphorylation | Uniprot | |
K151 | Ubiquitination | Uniprot | |
S157 | Phosphorylation | Uniprot | |
S166 | Phosphorylation | Uniprot | |
S171 | Phosphorylation | Uniprot | |
T176 | Phosphorylation | Uniprot | |
S180 | Phosphorylation | Uniprot | |
S189 | Phosphorylation | Uniprot | |
S191 | Phosphorylation | Uniprot | |
T197 | Phosphorylation | Uniprot | |
T198 | Phosphorylation | Uniprot | |
K217 | Ubiquitination | Uniprot | |
K219 | Ubiquitination | Uniprot | |
T221 | Phosphorylation | Uniprot | |
T222 | Phosphorylation | Uniprot | |
S223 | Phosphorylation | Uniprot | |
K225 | Ubiquitination | Uniprot | |
S228 | Phosphorylation | Uniprot | |
S231 | Phosphorylation | Uniprot | |
T234 | Phosphorylation | Uniprot | |
S247 | Phosphorylation | Uniprot | |
S274 | Phosphorylation | Uniprot | |
K297 | Sumoylation | Uniprot | |
K298 | Ubiquitination | Uniprot | |
K300 | Acetylation | Uniprot | |
K300 | Ubiquitination | Uniprot | |
K306 | Acetylation | Uniprot | |
K306 | Sumoylation | Uniprot | |
K306 | Ubiquitination | Uniprot | |
S327 | Phosphorylation | Uniprot | |
S328 | Phosphorylation | Uniprot | |
S331 | Phosphorylation | Uniprot | |
S334 | Phosphorylation | Uniprot | |
T335 | Phosphorylation | Uniprot | |
S350 | Phosphorylation | Uniprot | |
S362 | Phosphorylation | Uniprot | |
K366 | Sumoylation | Uniprot | |
K366 | Ubiquitination | Uniprot | |
K387 | Sumoylation | Uniprot | |
S389 | Phosphorylation | Uniprot | |
S394 | Phosphorylation | Uniprot | |
K396 | Sumoylation | Uniprot | |
S407 | Phosphorylation | Uniprot | |
S409 | Phosphorylation | Uniprot | |
S410 | Phosphorylation | Uniprot | |
S419 | Phosphorylation | Uniprot | |
K430 | Acetylation | Uniprot | |
K430 | Ubiquitination | Uniprot | |
S445 | Phosphorylation | Uniprot | |
S451 | Phosphorylation | Uniprot | |
S452 | Phosphorylation | Uniprot | |
S453 | Phosphorylation | Uniprot | |
S456 | Phosphorylation | Uniprot | |
S459 | Phosphorylation | Uniprot | |
S476 | Phosphorylation | Uniprot | |
K486 | Acetylation | Uniprot | |
S512 | Phosphorylation | Uniprot | |
S524 | Phosphorylation | Uniprot | |
T525 | Phosphorylation | Uniprot | |
S530 | Phosphorylation | Uniprot | |
K557 | Ubiquitination | Uniprot | |
T560 | Phosphorylation | Uniprot | |
K564 | Ubiquitination | Uniprot | |
K594 | Ubiquitination | Uniprot | |
K601 | Ubiquitination | Uniprot | |
K613 | Ubiquitination | Uniprot | |
K673 | Ubiquitination | Uniprot | |
K731 | Acetylation | Uniprot | |
K733 | Acetylation | Uniprot | |
K733 | Methylation | Uniprot | |
K733 | Ubiquitination | Uniprot | |
K739 | Acetylation | Uniprot | |
K739 | Ubiquitination | Uniprot | |
K750 | Ubiquitination | Uniprot | |
T751 | Phosphorylation | Uniprot | |
Y752 | Phosphorylation | Uniprot | |
K764 | Acetylation | Uniprot | |
K764 | Ubiquitination | Uniprot | |
K786 | Ubiquitination | Uniprot | |
Y818 | Phosphorylation | Uniprot | |
Y836 | Phosphorylation | Uniprot |
研究背景
Together with PML, this tumor suppressor is a major constituent of the PML bodies, a subnuclear organelle involved in a large number of physiological processes including cell growth, differentiation and apoptosis. Functions as a transcriptional coactivator of ETS1 and ETS2 according to. Under certain conditions, it may also act as a corepressor of ETS1 preventing its binding to DNA according to. Through the regulation of ETS1 it may play a role in angiogenesis, controlling endothelial cell motility and invasion. Through interaction with the MRN complex it may be involved in the regulation of telomeres lengthening. May also regulate TP53-mediated transcription and through CASP8AP2, regulate FAS-mediated apoptosis. Also plays a role in infection by viruses, including human cytomegalovirus and Epstein-Barr virus, through mechanisms that may involve chromatin and/or transcriptional regulation.
Sumoylated. Sumoylation depends on a functional nuclear localization signal but is not necessary for nuclear import or nuclear body targeting.
Sumoylated. Sumoylated with SUMO1. Sumoylation depends on a functional nuclear localization signal but is not necessary for nuclear import or nuclear body targeting. Sumoylation may stabilize the interaction with CBX5.
Nucleus. Nucleus>PML body. Cytoplasm.
Note: Differences in the subnuclear localization of the different isoforms seem to exist and may also be cell cycle- and interferon-dependent. Accumulates in the cytoplasm upon FAS activation.
Nucleus.
Note: Forms a reticulate or track-like nuclear pattern with denser concentrations at the nuclear lamina and surrounding the nucleoli, a pattern reminiscent of heterochromatin-rich regions according to PubMed:11313457.
Widely expressed. Sp100-B is expressed only in spleen, tonsil, thymus, mature B-cell line and some T-cell line, but not in brain, liver, muscle or non-lymphoid cell lines.
Homodimer; isoforms are able to heterodimerize. Interacts with members of the HP1 family of nonhistone chromosomal protein, such as CBX5 and CBX3 via the PxVxL motif. Interacts with ETS1; the interaction is direct and modulates ETS1 transcriptional activity. Interacts with the MRN complex which is composed of two heterodimers RAD50/MRE11 associated with a single NBN; recruits the complex to PML-related bodies. Interacts with HIPK2; positively regulates TP53-dependent transcription. Interacts with CASP8AP2; may negatively regulate CASP8AP2 export from the nucleus to the cytoplasm. Interacts with SUMO1P1/SUMO5.
(Microbial infection) Interacts with Epstein-Barr virus EBNA-LP; this interaction is important for EBNA-LP coactivator activity.
(Microbial infection) Interacts with human cytomegalovirus/HHV-5 protein UL123; may play a role in infection by the virus.
The HSR domain is important for the nuclear body targeting as well as for the dimerization.
Contains one Pro-Xaa-Val-Xaa-Leu (PxVxL) motif, which is required for interaction with chromoshadow domains. This motif requires additional residues -7, -6, +4 and +5 of the central Val which contact the chromoshadow domain.
研究领域
· Human Diseases > Infectious diseases: Viral > Herpes simplex infection.
· Human Diseases > Cancers: Overview > Viral carcinogenesis.
限制条款
产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。
产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。
Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。产品仅供科学研究使用。不用于诊断和治疗。
产品未经授权不得转售。
Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.